idelvion 500 iu powder and solvent for solution for injection
dksh malaysia sdn. bhd. - albutrepenonacog alfa -
idelvion 1000 iu powder and solvent for solution for injection
dksh malaysia sdn. bhd. - albutrepenonacog alfa -
idelvion 2000 iu powder and solvent for solution for injection
dksh malaysia sdn. bhd. - albutrepenonacog alfa -
idelvion 250 iu
csl behring ltd., israel - albutrepenonacog alfa - powder and solvent for solution for injection - albutrepenonacog alfa 250 iu - coagulation factor ix - treatment and prophylaxis of bleeding in patients with haemophilia b (congenital factor ix deficiency).
idelvion powder and solvent for solution for injection 1000iuvial
csl behring pte. ltd. - albutrepenonacog alfa - injection, powder, lyophilized, for solution - albutrepenonacog alfa 1000iu/vial
idelvion powder and solvent for solution for injection 2000iuvial
csl behring pte. ltd. - albutrepenonacog alfa - injection, powder, lyophilized, for solution - albutrepenonacog alfa 2000iu/vial
idelvion powder and solvent for solution for injection 250iuvial
csl behring pte. ltd. - albutrepenonacog alfa - injection, powder, lyophilized, for solution - albutrepenonacog alfa 250iu/vial
idelvion powder and solvent for solution for injection 500iuvial
csl behring pte. ltd. - albutrepenonacog alfa - injection, powder, lyophilized, for solution - albutrepenonacog alfa 500iu/vial
idelvion
csl behring (nz) ltd - albutrepenonacog alfa 1000 [iu]; ; - powder for injection - 1000 iu - active: albutrepenonacog alfa 1000 [iu] excipient: hydrochloric acid mannitol polysorbate 80 sodium citrate dihydrate sucrose water for injection - idelvion is indicated in all patients with haemophilia b for: - routine prophylaxis to prevent or reduce the frequency of bleeding episodes - control and prevention of bleeding episodes - control and prevention of bleeding in the perioperative setting.
idelvion
csl behring (nz) ltd - albutrepenonacog alfa 2000 [iu]; ; - powder for injection - 2000 iu - active: albutrepenonacog alfa 2000 [iu] excipient: hydrochloric acid mannitol polysorbate 80 sodium citrate dihydrate sucrose water for injection - idelvion is indicated in all patients with haemophilia b for: - routine prophylaxis to prevent or reduce the frequency of bleeding episodes - control and prevention of bleeding episodes - control and prevention of bleeding in the perioperative setting.